ENO2 and paraganglioma: The use of an immunohistochemical panel, including EMA, cytokeratins, CD10, inhibin, S100 protein, NSE, and chromogranin has been proposed for the differential diagnosis of renal HBL versus CCRCC, adrenal carcinoma, and paraganglioma.